News: Abbott Laboratories (ABT)

ABT on New York Consolidated

46.05USD
19 Dec 2014
Price Change (% chg)

$0.28 (+0.61%)
Prev Close
$45.77
Open
$45.91
Day's High
$46.45
Day's Low
$45.78
Volume
11,329,197
Avg. Vol
5,097,938
52-wk High
$46.50
52-wk Low
$35.65

Search Stocks
Select another date:

Tue, Dec 23 2014

CORRECTED-Chilean quits company boards to fight U.S. insider trading charges

(Corrects company name to Abbott Laboratories from Abbot Laboratories, paragraphs 1-2)

Justice department alleges Omnicare received kickbacks from Abbott Labs

- The U.S. Justice Department has filed a complaint against Omnicare Inc, alleging that the largest U.S. provider of pharmacy services to the elderly received millions of dollars in kickbacks from Abbott Laboratories.

Justice dept alleges Omnicare received kickbacks from Abbott Labs

Dec 22 - The U.S. Justice Department has filed a complaint against Omnicare Inc, alleging that the largest U.S. provider of pharmacy services to the elderly received millions of dollars in kickbacks from Abbott Laboratories.

U.S. regulator charges two with insider trading in Abbott deal

NEW YORK/SANTIAGO - A former board member of Chile's CFR Pharmaceuticals SA was charged on Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories' $2.9 billion acquisition of CFR earlier this year.

U.S. regulator charges two Chileans with insider trading

NEW YORK/SANTIAGO - A former board member of Chile's CFR Pharmaceuticals SA was charged on Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories’ $2.9 billion acquisition of CFR earlier this year.

UPDATE 1-U.S. regulator charges two Chileans with insider trading

NEW YORK/SANTIAGO - A former board member of Chile's CFR Pharmaceuticals SA was charged on Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories' $2.9 billion acquisition of CFR earlier this year.

U.S. regulator charges two with insider trading in Abbott deal

NEW YORK/SANTIAGO - A former board member of Chile's CFR Pharmaceuticals SA was charged Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories’ $2.9 billion acquisition of CFR earlier this year.

U.S. regulator charges two with insider trading in Abbott deal

NEW YORK/SANTIAGO, Dec 22 - A former board member of Chile's CFR Pharmaceuticals SA was charged Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories' $2.9 billion acquisition of CFR earlier this year.

BRIEF-Abbott completes acquisition of Veropharm

* Says Abbott announced that it has acquired control of the company

Factbox: Another U.S. tax 'inversion' implodes, pending deals dwindle

- Another proposed U.S. corporate tax "inversion" deal collapsed on Friday when Irish food group Fyffes Plc and larger U.S. rival Chiquita Brands International Inc called off an agreement to combine.

Select another date:
Search Stocks